Ionbond AG

Relevant Expertise/Experience
• Utilisation of coatings within medical devices including artificial joint surfaces
• Industrial implementation of coatings technology
• Compliance with the regulatory requirements
• Commercialisation of coating technology
• Exploitation through standards

Role in the project
WP4 leader:
• Industrial scale-up of HIPIMS technology
• Manufacturing specimens for coating characterisation
• Manufacturing prototypes for pre-clinical assessment
• Exploitation through (a) standards and (b) coating commercialisation


Ionbond AG (Ib) employs approximately 900 people and operates from 40 coating service sites worldwide. Its total turnover is CHF 140 million. Ionbond is a global leader in surface enhancement technology, and has been actively engaged in providing coatings to the medical device industry for more than 20 years. The coating service business at Ionbond is split into tooling and components. The medical sector plays a strategic role in the growth of the company’s component segment. Ionbond is certified to ISO 13485 (quality management system for medical devices) at five coating service centres and additional certifications are planned. Besides the standard coating portfolio offered to customers in its daily business, Ionbond is permanently seeking technical and business advantages through innovation and has thus been involved in many research and development projects. In addition to its surface coating business, Ionbond is a leading manufacturer of advanced Chemical Vapour Deposition (CVD), PVD, PACVD and Chemical Vapour Aluminising (CVA) equipment, both for in-house use and for sale to original equipment manufacturers.

Partner contribution
Ib is leader of work package 4 and contributes industrial scale-up of HIPIMS technology, manufacture of specimens for coating characterisation, manufacture of prototypes for pre-clinical assessment, and exploitation through standards and through coating commercialisation.